Universitätsklinikum Regensburg

Hospital


Location: Regensburg, Germany (DE) DE

ISNI: 0000000091947179

ROR: https://ror.org/01226dv09

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen. (2015) Siegert I, Schödel J, Nairz M, Schatz V, Dettmer K, Dick C, Kalucka J, et al. Journal article, Original article Quantitative Assessment of Free Flap Viability with CEUS Using an Integrated Perfusion Software (2015) Geis S, Klein S, Prantl L, Dolderer J, Lamby P, Jung EM Journal article Long-term results after modified Epping procedure for trapeziometacarpal osteoarthritis (2015) Klein SM, Wachter K, Koller M, Vykoukal J, Geis S, Dolderer JH, Loibl M, Prantl L Journal article Factor duration of immobilization Faktor ruhigstellungsdauer (2015) Klein S, Geis S, Dolderer J Journal article Long-term NMDA receptor inhibition affects NMDA receptor expression and alters glutamatergic activity in developing rat hippocampal neurons. (2015) Sinner B, Friedrich O, Lindner R, Bundscherer A, Graf B Journal article, Original article Systematic Investigation of CMTM Family Genes Suggests Relevance to Glioblastoma Pathogenesis and CMTM1 and CMTM3 as Priority Targets (2015) Delic S, Thuy A, Schulze M, Proescholdt MA, Dietrich P, Boßerhoff AK, Riemenschneider MJ Journal article Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat (2015) Kob R, Fellner C, Bertsch T, Wittmann A, Mishura D, Sieber C, Fischer B, et al. Journal article ISAR-SAFE: A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting (2015) Schulz-Schuepke S, Byrne RA, Ten Berg JM, Neumann FJ, Han Y, Adriaenssens T, Toelg R, et al. Journal article MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015) Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al. Journal article Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? (2015) Kob R, Bollheimer C, Bertsch T, Fellner C, Djukic M, Sieber C, Fischer B Journal article, Review article